Synergistic Co-Targeting of BTK and BCL2 in Mantle Cell Lymphoma

被引：1
|
作者：
Li, Yangguang [1 ]
Bouchlaka, Myriam N. [2 ,3 ]
Grindle, Kreg [1 ]
Kahl, Brad S. [4 ]
Miyamoto, Shigeki [5 ]
Yang, David T. [6 ]
Capitini, Christian M. [7 ]
Rui, Lixin [8 ,9 ]
机构：
[1] Dept Med, Madison, WI USA
[2] Univ Madison, Dept Pediat, Madison, WI USA
[3] Univ Madison, Carbone Canc Ctr, Madison, WI USA
[4] Washington Univ, St Louis, MO USA
[5] Dept Oncol, Madison, WI USA
[6] Carbone Canc Ctr, Madison, WI USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI USA
[8] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
    Dupont, Thibault
    Yang, ShaoNing
    Patel, Jayeshkumar
    Hatzi, Katerina
    Malik, Alka
    Tam, Wayne
    Martin, Peter
    Leonard, John
    Melnick, Ari
    Cerchietti, Leandro
    ONCOTARGET, 2016, 7 (03) : 3510 - 3522
  • [22] Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-protein-expression" lymphoma with MYC and BCL2 rearrangements
    Uchida, Akiko
    Isobe, Yasushi
    Asano, Junko
    Uemura, Yu
    Hoshikawa, Masahiro
    Takagi, Masayuki
    Miura, Ikuo
    HAEMATOLOGICA, 2019, 104 (07) : 1417 - 1421
  • [23] Co-targeting Aurora kinase A and Bcl-2 synergistically inhibits the viability in double-hit lymphoma cells
    Kong, Ling-Zhe
    Jia, Xiao-Hui
    Song, Zheng
    Qiu, Li-Hua
    Li, Lan-Fang
    Qian, Zheng-Zi
    Zhou, Shi-Yong
    Liu, Xian-Ming
    Ren, Xiu-Bao
    Meng, Bin
    Fu, Kai
    Wang, Ping
    Wang, Xian-Huo
    Zhang, Hui-Lai
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (04) : 746 - +
  • [24] Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma
    Durand, Romane
    Bellanger, Celine
    Kervoelen, Charlotte
    Tessoulin, Benoit
    Dousset, Christelle
    Menoret, Emmanuelle
    Asnagli, Helene
    Parker, Andrew
    Beer, Philip
    Pellat-Deceunynck, Catherine
    Chiron, David
    HAEMATOLOGICA, 2024, 109 (08) : 2574 - 2584
  • [25] Selective Inhibitor of Nuclear Export Selinexor (KPT-330) and BCL2 Inhibitor ABT-199 Enhance the Anti-Lymphoma Effect of BTK Inhibitor Ibrutinib in Mantle Cell Lymphoma
    Tabe, Yoko
    Harada, Masako
    Miyamae, Yuka
    Kazuno, Saiko
    Fujimura, Tsutomu
    Ueno, Takashi
    Miida, Takashi
    Konopleva, Marina
    Andreeff, Michael
    BLOOD, 2014, 124 (21)
  • [26] Dual Targeting of ROR1 and BTK Augments the Anti-Lymphoma Activity in Mantle Cell Lymphoma
    Nie, Lei
    Jiang, Vivian Changying
    Liu, Yang
    McIntosh, Joseph
    Vargas, Jovanny
    Cai, Qingsong
    Wang, Michael L.
    BLOOD, 2023, 142
  • [27] Targeting MCL1 and BCL2 in diffuse large B-cell lymphoma.
    Li, Lingxiao
    Pongtornpipat, Praechampoo
    Park, Soyoung
    Schatz, Jonathan Harry
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Advances in the treatment of mantle cell lymphoma with BTK inhibitors
    Shen, Jiwei
    Li, Jiawei
    Yang, Rui
    Wu, Shuang
    Mu, Zhimei
    Ding, Shi
    Zhang, Xinyu
    Duo, Meiying
    Chen, Ye
    Liu, Ju
    LEUKEMIA RESEARCH, 2024, 147
  • [29] Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma
    Liu, Xiaoqian
    Xu, Senlin
    Zhang, Jiawei
    Fan, Mingjie
    Xie, Jun
    Zhang, Bingfeng
    Li, Hongzhi
    Yu, Guohua
    Liu, Yinghui
    Zhang, Yuanfeng
    Song, Joo
    Horne, David
    Chan, Wing C.
    Chu, Xiaoxia
    Huang, Wendong
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 356 - 369
  • [30] A BTK INHIBITOR IS EFFECTIVE IN MANTLE-CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2013, 3 (08) : 839 - 839
12345